Medtronic Appoints New Director Robert L. Lerman
Ticker: MDT · Form: 8-K · Filed: Jun 26, 2024 · CIK: 1613103
| Field | Detail |
|---|---|
| Company | Medtronic PLC (MDT) |
| Form Type | 8-K |
| Filed Date | Jun 26, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-appointment, governance, personnel
Related Tickers: MDT
TL;DR
Medtronic adds MIT prof/ex-Labor Dept economist Robert Lerman to its board.
AI Summary
On June 21, 2024, Medtronic plc announced the appointment of Robert L. Lerman as a new independent director to its Board of Directors, effective immediately. Lerman brings extensive experience in compensation and human capital management, having previously served as Chief Economist for the U.S. Department of Labor and as a professor at MIT. His appointment is part of the company's ongoing efforts to strengthen its board's expertise.
Why It Matters
The addition of a director with expertise in compensation and human capital management could influence future executive pay structures and talent strategies at Medtronic.
Risk Assessment
Risk Level: low — The appointment of a new director is a routine corporate governance event with no immediate financial implications.
Key Players & Entities
- Medtronic plc (company) — The company filing the 8-K
- Robert L. Lerman (person) — Newly appointed independent director
- U.S. Department of Labor (company) — Former employer of Robert L. Lerman
- MIT (company) — Former employer of Robert L. Lerman
FAQ
When was Robert L. Lerman appointed to Medtronic's Board of Directors?
Robert L. Lerman was appointed to Medtronic's Board of Directors effective June 21, 2024.
What is Robert L. Lerman's primary area of expertise?
Robert L. Lerman's primary area of expertise is compensation and human capital management.
What previous roles has Robert L. Lerman held?
Robert L. Lerman previously served as Chief Economist for the U.S. Department of Labor and as a professor at MIT.
What is Medtronic's standard industrial classification?
Medtronic's standard industrial classification is ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845].
What is Medtronic's fiscal year end?
Medtronic's fiscal year end is April 26.
Filing Stats: 917 words · 4 min read · ~3 pages · Grade level 8.7 · Accepted 2024-06-26 09:01:25
Key Financial Figures
- $0.0001 — registered Ordinary shares, par value $0.0001 per share MDT New York Stock Exchange
Filing Documents
- mdt-20240621.htm (8-K) — 62KB
- exhibit991-pressreleasedat.htm (EX-99) — 11KB
- image_0.jpg (GRAPHIC) — 147KB
- 0001613103-24-000076.txt ( ) — 565KB
- mdt-20240621.xsd (EX-101.SCH) — 7KB
- mdt-20240621_def.xml (EX-101.DEF) — 24KB
- mdt-20240621_lab.xml (EX-101.LAB) — 50KB
- mdt-20240621_pre.xml (EX-101.PRE) — 26KB
- mdt-20240621_htm.xml (XML) — 18KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. A copy of the press release announcing Ms. Parkhill's departure and Mr. Corona's appointment is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 7.01 (including Exhibit 99.1) shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) List of Exhibits Exhibit Number Description 99.1 Press release of Medtronic plc, dated June 26, 2024 104 Cover Page Interactive Data File (embedded with the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Medtronic plc By /s/ Ivan K. Fong Date: June 26, 2024 Ivan K. Fong Executive Vice President, General Counsel and Secretary